CareTrust REIT prices 19.55 million shares under forward sale deals
- US stocks
- Agreement
- Real Estate

CareTrust REIT (NYSE: CTRE) said on 13 Nov 2026 that it entered into forward sale agreements covering 19,550,000 shares of common stock, including an underwriter option exercised in full. The initial forward sale price is $36.00 per share, and settlement must occur no later than 12 Nov 2027. The filing does not give gross or net proceeds.
Key highlights
- Forward sale agreements: 19,550,000 shares in total, 17,000,000 under the initial agreements and 2,550,000 under the additional agreements
- Initial forward sale price: $36.00 per share, subject to adjustments
- Underwriter option: additional 2,550,000 shares, exercised in full on 12 Nov 2026
- Settlement deadline: 12 Nov 2027
The offering in numbers
| Item | Detail |
|---|---|
| Issuer | CareTrust REIT, Inc. and its operating partnership, CTR Partnership, L.P. |
| Forward purchasers | Bank of America, N.A. and Morgan Stanley & Co. LLC |
| Underwriter representatives | BofA Securities, Inc. and Morgan Stanley & Co. LLC |
| Initial forward sale agreements | 17,000,000 shares, dated 11 Nov 2026 |
| Additional forward sale agreements | 2,550,000 shares, dated 12 Nov 2026 |
| Initial forward sale price | $36.00 per share |
| Shares borrowed and sold to underwriters on 13 Nov 2026 | 19,550,000 shares |
| Settlement deadline | 12 Nov 2027 |
Forward sales cover 19.55 million shares
CareTrust REIT entered into separate forward sale agreements with Bank of America, N.A. and Morgan Stanley & Co. LLC. The initial agreements, dated 11 Nov 2026, cover 17,000,000 shares of common stock, and additional agreements dated 12 Nov 2026 cover 2,550,000 shares.
The underwriters exercised in full a 30-day option to buy an additional 2,550,000 shares. The forward purchasers borrowed and sold an aggregate of 19,550,000 shares to the underwriters on 13 Nov 2026. The offering was made under an automatic shelf registration statement on Form S-3 filed on 17 Feb 2026 and a prospectus supplement dated 11 Nov 2026.
Settlement terms and the company's stated plan
The company says it intends to deliver shares on dates it specifies, no later than 12 Nov 2027, in exchange for cash equal to the forward sale price. The company says it expects to settle entirely by physical delivery of shares for cash proceeds, but may instead elect cash or net share settlement.
The forward sale price starts at $36.00 per share and is adjusted daily based on a floating interest rate factor, less a spread, and decreases by set amounts on specified dates.
Early settlement could dilute earnings per share
Each forward purchaser may accelerate its agreement in certain circumstances, including if it cannot hedge its exposure, if the company declares certain cash dividends, if an ownership threshold is crossed, or after a merger, tender offer, delisting or similar event. The company notes that such an accelerated settlement could be decided regardless of its capital needs, and that it could lead to dilution of earnings per share and affect the market price of the common stock.
Each agreement terminates automatically on certain bankruptcy or insolvency filings by the company, subject to exceptions.
What it means for CareTrust REIT shareholders
For existing holders, the filing shows the number of shares that may be issued under these agreements but not the proceeds, so the per-share effect cannot be measured from the filing. The filing does not state gross or net proceeds, the public offering price before discounts, the underwriting discount, the intended use of proceeds, or the effect on leverage.
The next dated step is settlement of the forward sale agreements on dates the company specifies, no later than 12 Nov 2027.
Filed with the US SEC on . Reference: Original filing (SEC)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

